Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.
about
Vigabatrin versus carbamazepine monotherapy for epilepsyVigabatrin versus carbamazepine monotherapy for epilepsyVigabatrin versus carbamazepine monotherapy for epilepsyCPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.Validation of the rat model of cryptogenic infantile spasms.Does the Swedish Interactive Threshold Algorithm (SITA) accurately map visual field loss attributed to vigabatrin?Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin.Pharmacogenomics and epilepsy: the road ahead.Mechanism of action of vigabatrin: correcting misperceptions.Population pharmacokinetics analysis of vigabatrin in adults and children with epilepsy and children with infantile spasms.Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations.GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment.
P2860
Q24187744-D7BAE3A8-7A15-42D5-BE90-5E3BD59AA50FQ24203845-1FF5E7C6-F8AF-493F-832B-2C31A80B0DB6Q24235055-37ECFE77-1949-4231-8F05-EBFAA1328C3FQ30584190-83AD6D9F-64DE-4E93-A147-9D04BA63BFF7Q35204574-04918126-C843-4F76-B41C-B13864B9FB54Q35336784-78A72073-1DE0-4CA0-8BEE-2DFB09645FE7Q36586336-E73D5AF8-9A8D-45F7-8BE7-9394CA2EEFB1Q37946957-63BD1906-512C-42E3-87B1-C3D33E9DF17DQ37953574-E98EB756-8E06-461F-852E-F63DD2B65784Q42679724-41C21394-A79D-4F57-A18E-C39BD99CDA40Q48552376-04B29EA1-72C2-4538-9470-3D28CB0CF5E5Q52098966-7439B671-8E47-4745-A1F2-F9A6393ACD16
P2860
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vigabatrin: a comprehensive re ...... following recent FDA approval.
@en
Vigabatrin: a comprehensive re ...... following recent FDA approval.
@nl
type
label
Vigabatrin: a comprehensive re ...... following recent FDA approval.
@en
Vigabatrin: a comprehensive re ...... following recent FDA approval.
@nl
prefLabel
Vigabatrin: a comprehensive re ...... following recent FDA approval.
@en
Vigabatrin: a comprehensive re ...... following recent FDA approval.
@nl
P2860
P1476
Vigabatrin: a comprehensive re ...... following recent FDA approval.
@en
P2093
Justin A Tolman
Michele A Faulkner
P2860
P304
P356
10.1517/14656560903451690
P407
P577
2009-12-01T00:00:00Z